Ktena, Y. P., Burris, M., Berger, R., Duke, K., Newton, S., Rodenbush, K., Murphy, J. D., Vindiola, L., Cooke, L. M., Tsai, H.-L., Bonifant, C. L., Chen, A. R., Gamper, C. J., Llosa, N. J., Zambidis, E. T., Liddle, K., Jones, R. J., Bolaños-Meade, J., Symons, H. J. and Cooke, K. R. (2026) “Reduced intensity hematopoietic cell transplant using best available donor and post-transplant cyclophosphamide is safe and curative for transfusion-dependent thalassemia”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301748.